Research
Lysine- R 2HGylation-C5 identified as a post-translational modification in R 2HG-elevated cancers
The Brief
- R-2-hydroxyglutarate is a cancer-linked metabolite whose mechanisms are incompletely understood.
- The authors identify lysine R2HGylation as a protein post-translational modification and structurally characterize it.
- The findings are reported in a Nature Communications paper published online on 18 November 2026.
Why it matters
A previously unrecognized protein modification linked to a cancer-associated metabolite could help explain how R-2-hydroxyglutarate affects cancer cells, which may inform future research on these tumours.
Who’s affected
- cancer biologists
- metabolism researchers
- #metabolism
- #post-translational modification
- #cancer
- #2-hydroxyglutarate
- #protein chemistry
Nature Communications, Published online: 18 November 2026; doi:10.1038/s41467-026-79668-2 R-2-hydroxyglutarate is a cancer-linked metabolite whose mechanisms are incompletely understood. Here, the authors identify and structurally characterize lysineR2HGylation as a protein…